Elizabeth Webster
Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
About Elizabeth Webster
Elizabeth Webster is recorded as Analyst at Goldman Sachs. Elizabeth Webster has spoken on 2 investor events across 2 companies, most recently for Upstream Bio, Inc. on June 10, 2026. Those appearances were for Upstream Bio, Inc. (UPB) and Maze Therapeutics, Inc. (MAZE). The companies whose calls Elizabeth Webster spoke on are classified in the Healthcare sector.
Elizabeth Webster on recent calls
“And today with us we have Ran Sutherland, the CEO of Upstream Bio. And Ran, to start, can you introduce Upstream, your lead assets, and how you see the company position today and where you're most focused as we head into the second half of the year?”
“I'm on the biotechnology equity research team here at Goldman Sachs, and today we have with us Jason Coloma, the CEO of Maze Therapeutics. Thank you, Jason, for being with us.”
Affiliation history
-
Goldman Sachs
Analyst
Transcript header (unverified)
Current